pharmaceuticals

The Advantage Johnson & Johnson's Phase 3 COVID-19 Study Has Over Rivals
The race for the COVID-19 vaccine is still very much on, and Johnson & Johnson just announced the launch of a Phase 3 trial.
Jon C. Ogg
1 day ago
Last Updated: 1 day ago

Why This Interim Liver Study Is Huge for Arrowhead Pharma
Arrowhead Pharmaceuticals has announced positive interim 24-week liver biopsy results in four subjects from its midstage study of ARO-AAT. Shares rallied on the news early Wednesday. 
Chris Lange
8 days ago

As CDC Issues Notice, Stock Market Bets Which Company Gets First COVID-19 Vaccine FDA Approval
America and the rest of the world is getting ready for a vaccine that will help protect public health against the COVID-19 pandemic. The societal impact of the coronavirus has changed many lives, and...
Jon C. Ogg
21 days ago

3 COVID-19 Vaccine Trials Are Now in Phase 3, With More on the Way
Three U.S. COVID-19 vaccine trials are now in Phase 3 studies. All three appear to have some serious benefits, but none are approved yet.
Jon C. Ogg
23 days ago

Why Dividend-Paying Big Drug Companies May Be the Best Stocks to Own Now
These five dividend-paying large-cap pharmaceutical stocks look like outstanding ideas for nervous investors looking for income and a degree of safety. They have come way in from their 52-week...
Lee Jackson
28 days ago

The Data Just Keeps Getting Better for Pfizer and BioNTech's COVID-19 Vaccine
Pfizer and BioNTech provided an update for their coronavirus vaccine that is currently in the late stages of development and testing.
Chris Lange
1 month ago

Johnson & Johnson's Newest Multibillion Dollar Acquisition
After Momenta Pharmaceuticals announced that it would be acquired by pharmaceutical giant Johnson & Johnson, the biotechnology company's shares soared on Wednesday.
Chris Lange
1 month ago

Vanda Pharma's Big Step Forward in COVID-19 Pneumonia
Vanda Pharmaceuticals took another big step forward in the fight against COVID-19 on Tuesday morning.
Chris Lange
1 month ago

What Sanofi Is Adding to Its Portfolio With This New Acquisition
Principia Biopharma shares jumped to start out the week after it was announced that it would be acquired by Sanofi.
Chris Lange
1 month ago

Moderna's New Deal: Is This a Case of 'Sell the News'?
When Moderna announced a new deal with the U.S. government for its COVID-19 vaccine, it appeared be a case of “sell the news,” because this is ultimately a net positive for the company.
Chris Lange
1 month ago

How Is Royalty Pharma Poised After Earnings?
Royalty Pharma reported quarterly results on Wednesday morning that were boosted by Imbruvica and the addition of new royalties.
Chris Lange
1 month ago

Biogen Has Potentially Great News in the Fight Against Alzheimer's
The world may be focused on COVID-19 this year, but the battle against Alzheimer’s disease continues with no effective treatments. Biogen hopes to remedy that unfortunate situation.
Jon C. Ogg
1 month ago

5 Large Biotech and Pharma Stocks Are Dirt Cheap, and Not Because of COVID-19
24/7 has compiled a few biopharmaceutical names that have lagged the markets and recently have reported earnings. In a sense, the fundamentals have shown some light on these stocks, that they may be...
Chris Lange
1 month ago
Last Updated: 1 month ago

Is Regneron's COVID-19 Animal Study Giving More Creedence to Antibody Treatments?
Regeneron Pharmaceuticals, one of the front-runners for the development of a COVID-19 treatment, released an update on its antibody drug combination on Monday.
Chris Lange
1 month ago

How GW Pharma Is Expanding Its Cannabidiol Seizure Treatment
GW Pharmaceuticals shares popped early on Monday morning after the company announced that it received a key approval from the FDA for Epidiolex to treat certain seizures.
Chris Lange
1 month ago